Commentary: ART: Let it rest in peace

The Arterial Revascularization Trial (ART) was a multicenter, prospective trial consisting of 3102 patients who underwent coronary artery bypass graft (CABG) randomized to receive either bilateral internal thoracic artery (BITA) or single internal thoracic artery (SITA) grafts along with guideline-directed medical therapy (GDMT).1 Both groups received saphenous vein grafts (SVGs), and 21.8% of the SITA and 19.4% of the BITA patients also received a radial artery (RA) graft. After 10  years, there was no significant difference between the groups in mortality from any cause, or the composite endpoint of death, myocardial infarction (MI), stroke, or the need for a repeat revascularization.
Source: The Journal of Thoracic and Cardiovascular Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Tags: Commentary Source Type: research